These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11933860)

  • 61. [Management of non alcoholic fatty liver diseases in adults].
    Pariente A
    Rev Prat; 2012 Dec; 62(10):1421-5. PubMed ID: 23424926
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.
    Clark JM; Diehl AM
    JAMA; 2003 Jun; 289(22):3000-4. PubMed ID: 12799409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
    Contos MJ; Sanyal AJ
    Adv Anat Pathol; 2002 Jan; 9(1):37-51. PubMed ID: 11756758
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nonalcoholic steatohepatitis and the cardiometabolic syndrome.
    Abdeen MB; Chowdhury NA; Hayden MR; Ibdah JA
    J Cardiometab Syndr; 2006; 1(1):36-40. PubMed ID: 17675901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.
    Pagadala MR; McCullough AJ
    Clin Liver Dis; 2012 Aug; 16(3):487-504. PubMed ID: 22824477
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in the understanding and treatment of nonalcoholic fatty liver disease.
    Harrison SA; Di Bisceglie AM
    Drugs; 2003; 63(22):2379-94. PubMed ID: 14609346
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of liver biopsy in the assessment of non-alcoholic fatty liver disease.
    Hübscher SG
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1107-15. PubMed ID: 15489567
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nonalcoholic fatty liver disease: a clinical review.
    Sass DA; Chang P; Chopra KB
    Dig Dis Sci; 2005 Jan; 50(1):171-80. PubMed ID: 15712657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonalcoholic fatty liver disease: pathology and pathogenesis.
    Tiniakos DG; Vos MB; Brunt EM
    Annu Rev Pathol; 2010; 5():145-71. PubMed ID: 20078219
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A clinical and pathological study of nonalcoholic fatty liver disease].
    Zheng RD; Lu LG; Meng JR; Huang JD; Rao RC; Xu CR; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):449-52. PubMed ID: 16792871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA; Bacon BR
    Med Clin North Am; 1996 Sep; 80(5):1147-66. PubMed ID: 8804378
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report.
    Méndez-Sánchez N; Motola-Kuba D; Bahena-Aponte J; Chavez-Tapia N; Pichardo-Bahena R; Uribe M
    Ann Hepatol; 2003; 2(4):183-5. PubMed ID: 15115959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NASH and cryptogenic cirrhosis: a histological analysis.
    Caldwell SH; Lee VD; Kleiner DE; Al-Osaimi AM; Argo CK; Northup PG; Berg CL
    Ann Hepatol; 2009; 8(4):346-52. PubMed ID: 20009134
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
    Ludwig J; Viggiano TR; McGill DB; Oh BJ
    Mayo Clin Proc; 1980 Jul; 55(7):434-8. PubMed ID: 7382552
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nonalcoholic steatohepatitis: a study of 49 patients.
    Lee RG
    Hum Pathol; 1989 Jun; 20(6):594-8. PubMed ID: 2656500
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction.
    Fujikawa K; Ohata K; Honda T; Miyazoe S; Ichikawa T; Ishikawa H; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    Intern Med; 2004 Apr; 43(4):289-94. PubMed ID: 15168770
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication].
    Larrey D
    Presse Med; 2003 Mar; 32(11):512-8. PubMed ID: 12733392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
    Matteoni CA; Younossi ZM; Gramlich T; Boparai N; Liu YC; McCullough AJ
    Gastroenterology; 1999 Jun; 116(6):1413-9. PubMed ID: 10348825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.